ARTICLE | Company News
Novartis, Torrent autoimmune news
October 26, 2015 7:00 AM UTC
The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (PTO) found that U.S. Patent No. 8,324,283 covering Novartis’ Gilenya fingolimod is unpatentable for obviousness. Torr...